It’s going to take a lot more than a reverse stock split to provide support for Support.com’s saggy share price. When Cell Therapeutics, Inc. announced it was changing its name to CTI BioPharma Corp (NASDAQ:CTIC) …
Shares of CTI BioPharma Corp. (NASDAQ:CTIC) slipped more than 10% in trade today after the company issued a press release yesterday, in which it announced it will put up its Series 21 Preferred Stock in an underwritten …
CTI Biopharma (NASDAQ: CTIC) CTIC has had a very interesting time in the market this week. After presenting data from its study known as PERSIST-1 at the ASCO 2015 presentation, the company's stock climbed …
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is CTI BioPharma Corp. CTIC. This Medicine – Drugs stock has actually seen estimates improve over the past …
The ASCO 2015 meeting is proving to be a big hit in the world of biotech; and CTIC is making waves. CTI BioPharma Corp (NASDAQ:CTIC) and Baxter International’s Bioscience announced data from a Phase 3 …
SEATTLE, Jan. 9, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced positive progress ... Register now to create your own custom streaming stock watchlist. NYSE, …
Progress
One stock that might be an intriguing choice for investors right now is CTI BioPharma Corp. CTIC. This is because this security in the Medical-Drugs space is seeing solid earnings estimate revision activity, and is in great …
NASDAQ11mon
NASDAQ
BioCryst and Sarepta Biotech Stock Roundup: Alexion, Regeneron Miss Estimates; Setback for CTI BioPharma CTI BioPharma (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape CTI BioPharma Corp. (CTIC) …